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Successful drug discovery often requires optimization
against a set of biological and physical properties. We
describe our work on multi-parameter approaches to
ligand-based de novo design and studies that demon-
strate its ability to successfully generate lead hops or
scaffold hops between known classes of ligands for some
example receptors. We describe a multi-criteria scoring
function incorporating molecular shape similarity, mole-
cular fingerprint similarity, and a number of popular
“Lipinski-like” molecular properties.
Muse is based on an evolutionary algorithm that oper-
ates on an initial population of structures to invent new
structures with improved scores. Muse is unique in that
it has the ability to work with any user-defined scoring
function that provides results in the form of a numerical
evaluation of designed structures.
Several retrospective studies on various targets
demonstrate the ability of the above mentioned
approach to generate novel ideas that are not only
appealing to design scientists but are also validated by
comparison to compounds known to demonstrate activ-
ity at the desired biological target. Specific examples
where this approach has generated either significant
modifications of existing molecular frameworks or struc-
turally new molecular templates relative to design start-
ing points (i.e., lead hopping) will be provided.
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